Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Basolateral potassium channels in intestinal epithelial cells are crucial for maintaining electrolyte and fluid homeostasis. They facilitate potassium efflux from the cell into the interstitial space, supporting nutrient absorption, chloride secretion, and membrane potential maintenance. KCa3.1 (KCNN4) is a prominent subtype in human colonocytes. Dysfunction is linked to gastrointestinal disorders like IBD-associated diarrhea. Pharmacological agents like clotrimazole can modulate their activity, affecting wound healing and inflammatory responses.
Inhibition of potassium channel activity, leading to reduced potassium efflux and altered membrane potential
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Basolateral Potassium Channel (Intestinal).